Deals
Constellation Energy Sets $12.50–$12.80 Earnings Outlook And Agrees To Buy $715 Million Plant
Calpine and stronger commercial results lifted quarterly earnings, while Amazon and Google agreements support nuclear expansion.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Deals
Calpine and stronger commercial results lifted quarterly earnings, while Amazon and Google agreements support nuclear expansion.
Deals
Fee earnings rose 27%, but insurance earnings fell as Global Atlantic's annual assumptions review switched from a benefit to a charge.
Earnings
Cheaper Fintech funding offsets softer merchandise-sales trends, while the board proposes another KZT1,000 dividend per ADS.
SEC Filings
The company plans to ask whether approval is possible without additional clinical studies; the FDA raised no safety concerns.
SEC Filings
The forecast rests on offering proceeds, existing cash, spending discipline and access to further share sales.
Earnings
DAWNZERA sales and research partnerships lift third-quarter revenue while Ionis spends more on launching its own medicines.
Earnings
Power revenue rose 27.6% from the second quarter, but equipment expansion kept adjusted free cash flow below zero.
SEC Filings
The company targets an FDA application by year-end 2026 to reach patients receiving BCG for the first time.
Deals
Leggett & Platt lifted total sales, but acquisition costs weighed on reported profit as adjusted earnings rose.
Deals
Adjusted quarterly earnings rose 88%, while CNH agreed to sell majority control of its construction business to Kobelco.
SEC Filings
Expected sale proceeds support $3 billion in buybacks across 2026 and 2027, plus $3 billion of planned debt reduction in 2027.
Deals
The Swiss drug developer proposes 10,294,117 IPO shares as it funds antibody trials for respiratory and skin diseases.